Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inveresk To Add Allergy/Immunology Expertise Upon Merger With ClinTrials

Executive Summary

Inveresk Research will add allergy and immunology expertise to its contract research capabilities following its merger with Cary, N.C.-based ClinTrials.

You may also be interested in...



CROs Highlight Toxicology Revenue; Are Mergers Non-Toxic To Bottom Line?

Covance expects its expanding toxicology research to drive double-digit revenue growth through 2003

CROs Highlight Toxicology Revenue; Are Mergers Non-Toxic To Bottom Line?

Covance expects its expanding toxicology research to drive double-digit revenue growth through 2003

Corcept To Test Sluggish IPO Market For Biotechs

Corcept Therapeutics will test the sluggish market for biopharmaceutical initial public offerings with an IPO slated for June 10

Related Content

UsernamePublicRestriction

Register

PS037395

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel